MedPath

Cap Assisted Upper Endoscopy to Visualize the Major Duodenal Papilla

Not Applicable
Completed
Conditions
Visualisation and Evaluation of Ampulla of Vater
Registration Number
NCT02877797
Lead Sponsor
Technical University of Munich
Brief Summary

Aim of the present study is the evaluation of the diagnostic value of a cap assisted upper GI-endoscopy compared to a standard upper GI-endoscopy regarding the visualisation and evaluation of the papilla duodeni major.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
101
Inclusion Criteria
  • Indication of Esophagogastroduodenoscopy independent from the study
  • Written informed
  • Age ≥ 18 years
Exclusion Criteria
  • Absence of written informed consent
  • Contraindication or absence of informed consent regarding sedation with Propofol
  • Postoperativ changes of the upper GI-tract
  • Intention of endoscopic intervention
  • Suspicion of upper GI-bleeding
  • Suspicion of stenosis of the esophagus
  • Stent in the papilla duodeni major
  • ASA (American Society of Anesthesiologists) classification ≥ 3

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Rate of complete visualisation of papilla duodeni major120 seconds

visualisation: none, incomplete, complete

Secondary Outcome Measures
NameTimeMethod
time of investigationup to 10 minutes

Duration of Esophagogastroduodenoscopy

Diagnostic yield in the upper GI-tractup to 10 minutes

All pathological findings which are seen during the examination should be reported (e.g. reflux esophagitis, Barret's esophagus, duodenal erosions, etc)

complication rateup to one week

Any complications related to the examination within one week would be reported.

Trial Locations

Locations (1)

Klinikum rechts der Isar der Technischen Universität München

🇩🇪

Munich, Bavaria, Germany

Klinikum rechts der Isar der Technischen Universität München
🇩🇪Munich, Bavaria, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.